Biologics

Your Trusted Partner in Biologics Manufacturing

At Adragos Pharma, we specialize in the aseptic fill and finish of biologic drug products, providing comprehensive solutions tailored to clinical and commercial manufacturing. Our Jura, Switzerland facility, backed by over 20 years of expertise, ensures GMP and FDA-compliant production with the highest standards of quality and safety.

Why Choose Adragos Pharma for Biologics?

Expertise in Aseptic Fill & Finish

We offer specialized manufacturing for lyophilized and liquid sterile biologics with a strong focus on small-batch production for clinical and commercial needs. Our aseptic processes ensure sterility, safety, and efficacy at every stage.

Flexible & Scalable Manufacturing

✔ No minimum batch size – tailored production for your specific needs
Scale-up & technology transfer support
GMP-compliant process alignment from Phase I to III
Controlled temperature storage & shipment for biologic integrity

Comprehensive Development & Regulatory Support

Formulation & process development for optimal manufacturing
✔ Full GMP & FDA regulatory compliance with expert guidance
Aseptic Process Simulation (APS) to ensure sterilityscapes.

Analytical & Quality Control Excellence

We provide extensive quality control and analytical services to maintain biologic product safety and efficacy:
✔ HPLC, UPLC, and UV-Vis Spectrophotometry for purity testing
Endotoxin & sterility testing under isolators
Long-term stability studies under ICH conditions

End-to-End Biologics Manufacturing Solutions

From clinical batch production to commercial manufacturing, we support the entire biologics lifecycle with:
Aseptic liquid & lyophilized filling
Complex formulations & peptides handling
Small-volume sterile suspensions
Primary & secondary packaging

Download Our Brochure Now! 

We offer Biologics Services in
Jura, Switzerland

With more than 6,000 sqm of facilities and more than 25 years of experience, Adragos Jura offers customized clinical manufacturing to support your therapeutic trials.

Subscribe to our newsletter!

Get notified on our latest news.